DAVID
GARCIA AZORIN
PROFESOR ASOCIADO CIENCIAS DE LA SALUD
ANGEL LUIS
GUERRERO PERAL
PROFESOR ASOCIADO CIENCIAS DE LA SALUD
Publicaciones en las que colabora con ANGEL LUIS GUERRERO PERAL (82)
2024
-
CandeSpartan Study: Candesartan Spanish Response-prediction and Tolerability study in migraine
Cephalalgia : an international journal of headache, Vol. 44, Núm. 4
-
Effectiveness, tolerability, and response predictors of preventive anti-CGRP mAbs for migraine in patients over 65 years old: a multicenter real-world case-control study
Pain Medicine (United States), Vol. 25, Núm. 3, pp. 194-202
-
Evaluation of the concomitant use of prophylactic treatments in patients with migraine under anti-calcitonin gene-related peptide therapies: The PREVENAC study
European Journal of Neurology, Vol. 31, Núm. 5
-
Factors associated to the presence of headache in patients with influenza infection and its consequences: a 2010–2020 surveillance-based study
Journal of Headache and Pain, Vol. 25, Núm. 1
-
RE-START: Exploring the effectiveness of anti-calcitonin gene-related peptide resumption after discontinuation in migraine
European Journal of Neurology, Vol. 31, Núm. 4
2023
-
Cefalea: concepto, diagnóstico, criterios de alerta y exploraciones complementarias
Medicine: Programa de Formación Médica Continuada Acreditado, Serie 13, Núm. 71, pp. 4143-4152
-
Connectivity-based Meta-Bands: A new approach for automatic frequency band identification in connectivity analyses
NeuroImage, Vol. 280
-
Diferencias y similitudes entre la cefalea relacionada con la COVID-19 y la cefalea relacionada con la vacuna de la COVID-19. Un estudio de casos y controles
Revista de neurologia, Vol. 77, Núm. 10, pp. 229-239
-
Increased MRI-based Brain Age in chronic migraine patients
Journal of Headache and Pain, Vol. 24, Núm. 1
-
InfluenCEF study: Clinical phenotype and duration of headache attributed to influenza infection
Cephalalgia : an international journal of headache, Vol. 43, Núm. 11
-
Long-term effectiveness and tolerability of galcanezumab in patients with migraine excluded from clinical trials: real world evidence of 1055 patients with 1 year follow-up from the Galca-Only registry
Journal of Headache and Pain, Vol. 24, Núm. 1
-
Long-term outcomes of nummular headache: A series of 168 patients and 1198 patient-years of follow-up
Cephalalgia : an international journal of headache, Vol. 43, Núm. 9
-
Potential Predictors of Response to CGRP Monoclonal Antibodies in Chronic Migraine: Real-World Data
Current Pain and Headache Reports
-
Structural brain changes in patients with persistent headache after COVID-19 resolution
Journal of Neurology, Vol. 270, Núm. 1, pp. 13-31
-
Study about the Manchester Triage System subtriage in patients that visited the Emergency Department due to headache
Neurologia, Vol. 38, Núm. 4, pp. 270-277
-
Telemedicine in the management of patients with headache: current situation and recommendations of the Spanish Society of Neurology's Headache Study Group
Neurologia, Vol. 38, Núm. 9, pp. 635-646
-
Treatment of Primary Nummular Headache: A Series of 183 Patients from the NUMITOR Study
Journal of Clinical Medicine, Vol. 12, Núm. 1
-
Viability of AMURA biomarkers from single-shell diffusion MRI in clinical studies
Frontiers in Neuroscience, Vol. 17
2022
-
Amitriptyline for post-COVID headache: effectiveness, tolerability, and response predictors
Journal of Neurology, Vol. 269, Núm. 11, pp. 5702-5709
-
Cardio-Pulmonary Dysfunction Evaluation in Patients with Persistent Post-COVID-19 Headache
International Journal of Environmental Research and Public Health, Vol. 19, Núm. 7